Skip to content

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

← back to feed
Revenue (TTM)
$25.35M
+172.1% YoY Q3 Nov 2019
Net Income (TTM)
−$8.43M
−27.3% YoY Q3 Nov 2019
EPS Diluted (TTM)
—
Q3 Nov 2019
Gross Margin
68.9%
Q3 Nov 2019
Operating Margin
-23.2%
Q3 Nov 2019
Net Margin
-33.3%
Q3 Nov 2019
Free Cash Flow (TTM)
−$2.03M
Q3 Nov 2019
Cash
$1.56M
Q3 Nov 2019
Total Debt
$2.76M
Q3 Nov 2019
Shares Outstanding
2.76M sh
Q3 Nov 2019

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings